| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 07/21/2005 | US20050159431 Substituted alkyl uracils and thereof |
| 07/21/2005 | US20050159428 Nonpeptide and thus metabolically stable; diagnostic tool; amidation of the 4-carboxyquinoline derivative with a primary benzylamine |
| 07/21/2005 | US20050159411 Bactericides for infrections in man |
| 07/21/2005 | US20050158708 High thoughput assay; rapid profiling; proteomics |
| 07/21/2005 | DE10360154A1 New 2-(hetero)aryl-tetrahydroquinoline derivatives and 1,2,3,4-tetrahydro-1,5-naphthyridine derivatives are mitotic motor protein Eg5 inhibitors used as anticancer agents for treating carcinoma or leukemia |
| 07/21/2005 | CA2552739A1 Cysteine protease inhibitors |
| 07/21/2005 | CA2551952A1 Pyrrole and pyrazole daao inhibitors |
| 07/21/2005 | CA2549396A1 Cb1 modulator compounds |
| 07/21/2005 | CA2549330A1 Calcitonin gene related peptide receptor antagonists |
| 07/20/2005 | EP1554290A2 Analogs and prodrugs of buprenorphine |
| 07/20/2005 | EP1554283A1 5-substituted 7,9-difluoro-5 i h /i -chromeno (3,4-f) quinoline compounds as selective progesterone receptor modulators |
| 07/20/2005 | EP1554243A1 Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases |
| 07/20/2005 | EP1272484B1 Benzoamide piperidine compounds as substance p antagonists |
| 07/20/2005 | EP1056717B1 Arylphenyl-substituted cyclic keto-enols |
| 07/20/2005 | CN1642958A Crystalline polymorphic form of irinotecan hydrochloride |
| 07/20/2005 | CN1642944A (3Z) -3-(2, 3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 07/20/2005 | CN1642940A Bicyclic fused pyridinyl amides and advantageous compositions thereof for use as fungicides |
| 07/20/2005 | CN1642752A Optical recording media and dipyrromethene-metal chelate compounds |
| 07/20/2005 | CN1642580A Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 07/20/2005 | CN1642555A Statin therapy for enhancing cognitive maintenance |
| 07/20/2005 | CN1642552A 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| 07/20/2005 | CN1640877A Novel spiro compounds |
| 07/20/2005 | CN1211386C Antitumoral analogue of Et-743 |
| 07/20/2005 | CN1211373C 2,d-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 07/19/2005 | US6919450 Process for the preparation of benazepril |
| 07/19/2005 | US6919445 Detecting with a multicolor fluorescent dyes, for automated 4-DNA sequencing systems, identifying the classes of the polynucleotides |
| 07/14/2005 | WO2005064008A1 Method and compositions for identifying anti-hiv therapeutic compounds |
| 07/14/2005 | WO2005063769A1 Spirocyclic cyclohexane derivatives |
| 07/14/2005 | WO2005063768A1 Novel pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same |
| 07/14/2005 | WO2005063735A1 2-(hetero)-aryl-substituted tetrahydroquinoline derivatives |
| 07/14/2005 | WO2005063732A1 Compounds and methods for the treatment of asthma |
| 07/14/2005 | WO2005063704A1 Azetidine ring compounds and drugs comprising the same |
| 07/14/2005 | WO2005063680A1 Process for the preparation of arylamines |
| 07/14/2005 | WO2005062991A2 Ten and 20-di-esterification derivatives of camptothecins and methods to treat cancers |
| 07/14/2005 | WO2005062985A2 Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications |
| 07/14/2005 | WO2005062894A2 Co-administration of dopamine-receptor binding compounds |
| 07/14/2005 | WO2005062882A2 Rifamycin analogs and uses thereof |
| 07/14/2005 | US20050154199 Bridged macrocyclic module compositions |
| 07/14/2005 | US20050154028 1-(3-Fluoro-phenyl)-3-[4-methoxy-3-(2-piperidin-1-yl-ethoxy)-phenyl]-imidazolidin-2-one; serotonin 5-ht2c receptor antagonist; antidepressant and anxiolytic agent |
| 07/14/2005 | US20050154017 Novel azasugar derivative and drug containing the same as the active ingredient |
| 07/14/2005 | US20050154015 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 07/14/2005 | US20050154004 4-Phenyl-6H-(1)Benzopyrano(4',3':4,5)pyrrolo(2,1-a)isoquinolin-6-one's and analogues, optionally mixed with acceptable carriers, excipients or diluents, used for treating multidrug resistant tumors, for inducing apoptosis and as immunology modulators |
| 07/14/2005 | US20050154003 Containing a 1H,3H-furo[3',4':6,7]indolizino[1,2-b]quinoline ring, e.g., {10-[(E)-(ter-butoxyimino)methyl]-3-ethyl-1,13-dioxo-11,13-dihydro-1H,3H-furo[3',4':6,7]indolizino[1,2-b]quinolin-3-yl}acetic acid; topoisomerase I inhibitors used to treat cancer |
| 07/14/2005 | US20050153998 Tetrahydroisoquinoline or isochroman compounds |
| 07/14/2005 | US20050153989 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases |
| 07/14/2005 | US20050153942 Heterocyclic inhibitors of MEK and methods of use thereof |
| 07/14/2005 | US20050153355 Water-soluble rhodamine dye conjugates |
| 07/14/2005 | US20050152913 Process for preapring maytansinol |
| 07/14/2005 | CA2552207A1 Novel pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same |
| 07/14/2005 | CA2551611A1 Thiazole derivatives for treating or preventing parkinson's disease |
| 07/14/2005 | CA2550730A1 Method and compositions for identifying anti-hiv therapeutic compounds |
| 07/14/2005 | CA2550729A1 Rifamycin analogs and uses thereof |
| 07/14/2005 | CA2550650A1 Co-administration of dopamine-receptor binding compounds |
| 07/13/2005 | EP1553074A1 Fused benzene derivative and use |
| 07/13/2005 | EP1551846A1 Azabicyclic spiroether derivatives as receptor antagonists |
| 07/13/2005 | EP1551845A1 5-CYCLOALKENYL 5 i H /i -CHROMENO 3,4-F QUINOLINE DERIV ATIVES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS |
| 07/13/2005 | EP1551844A2 Antitumoral analogs of lamellarins |
| 07/13/2005 | EP1551829A2 Novel compounds with antibacterial activity |
| 07/13/2005 | EP1551826A1 Hydantoine derivatives and their use as tace inhibitors |
| 07/13/2005 | EP1551810A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
| 07/13/2005 | EP1551797A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 07/13/2005 | EP1551461A2 Azo compounds for type i phototherapy |
| 07/13/2005 | EP1551384A2 R-nsaid esters and their use |
| 07/13/2005 | EP1235802B1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 07/13/2005 | EP1042291B1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 07/13/2005 | EP0938308B1 Antiparasitic agents |
| 07/13/2005 | CN1639168A Bicyclic pyridine and pyrimidine P38 kinase inhibitors |
| 07/13/2005 | CN1639152A Pyrrole-2, 5-dione derivatives and their use as GSK-3 inhibitors |
| 07/13/2005 | CN1639146A Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
| 07/13/2005 | CN1639145A Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 07/13/2005 | CN1638763A Antidepressant |
| 07/13/2005 | CN1636997A Substituted tricyclocoumarin compound and its prepn and anti-HIV application |
| 07/13/2005 | CN1636996A Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| 07/13/2005 | CN1636990A Heterocyclic substituted aminoazacycles useful as central nervous system agents |
| 07/13/2005 | CN1210278C Ketol fatty acid derivatives, preparing method and plant growth regulating agents |
| 07/13/2005 | CN1210276C Plant extractive and alkaloid with cough-relieving activity |
| 07/13/2005 | CN1210265C Phthalazine derivatives and remedies for erectile dysfunction |
| 07/13/2005 | CN1210028C Aqueous liquid preparation |
| 07/12/2005 | US6916832 Nitrogen compounds such as 8,9-dihydroxy-1,2,3,11b-tetrahydro-chromeno(4,3,2-de)isoquinoline hydrobromide, administered for prophylaxis of nervous system disorders |
| 07/12/2005 | US6916825 Alkylated imidazopyridine derivatives |
| 07/12/2005 | US6916823 Method of treatment of dopamine-related dysfunction |
| 07/12/2005 | US6916819 Benzimidazole and pyridylimidazole derivatives |
| 07/12/2005 | US6916809 Heterocyclic acridone inhibitors of IMPDH enzyme |
| 07/12/2005 | CA2219660C Novel water-soluble fluoroethylcamptothecin derivative and process for production thereof |
| 07/09/2005 | CA2455018A1 Process for the preparation of piperidine derivatives |
| 07/07/2005 | WO2005061517A1 Process for making camptothecin derivatives |
| 07/07/2005 | WO2005061516A1 Novel chemical compounds |
| 07/07/2005 | WO2005061515A1 Vinylogous 4h-pyrones and their use in promoting plant growth |
| 07/07/2005 | WO2005061514A1 Pyrano-quinolines, pyrano-quinolinones, combinations thereof, photochromic compositions and articles |
| 07/07/2005 | WO2005061499A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 07/07/2005 | WO2005061484A1 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
| 07/07/2005 | WO2005061477A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | WO2005060963A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/07/2005 | WO2005037839A8 Norcantharidin derivative compounds, method for the production thereof, compositions containing said compounds and the use thereof |
| 07/07/2005 | US20050148778 One pot, industrial scale, low cost synthesis; forming diazonium salt of 4-[1,2,4]triazol-1ylmethyl-aniline HCL, reducing, acidifying; reacting intermediate with keto-valerolactone then fischer indole converting followed by transesterification, amination, saponification decarboxylation |
| 07/07/2005 | US20050148650 protein kinase B activating agents for preventing or treating depression, PTSD, Parkinson's disease, Alzheimer's diseases, and the like; comprises for e.g. [1] 2-[2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran-5-yl]isoindoline |
| 07/07/2005 | US20050148631 Modulation of steroid enzymes in mammals as antidiabetic agents, for treatment of obesity, vision defects, lowering fats in blood, for treatment of osteoporosis, tuberculosis or atherosclerosis in mammals |
| 07/07/2005 | US20050148610 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 07/07/2005 | US20050148603 Compositions useful as inhibitors of protein kinases |
| 07/07/2005 | US20050148593 Compounds, compositions, and methods |